2019-06 TRISCEND Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 228 participants.
Also called NCT04221490
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 228 participants
- Sponsor
- Registry
-
NCT04221490
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Results first posted
- Countries
- United States, Canada, France, Switzerland
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04221490. Allocation not applicable; no masking; primary purpose treatment. Start 2020-05-06 (actual); primary completion 2024-01-05 (actual). Results posted on 2025-01-09.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- 2019-06 TRISCEND Study
- Condition
- Tricuspid Valve Regurgitation
- Condition
- Heart Valve Diseases
- Condition
- Cardiovascular Diseases
- Intervention (Device)
- Transcatheter Tricuspid Valve Replacement
- Lead sponsor
- Edwards Lifesciences
Record details
- Record id
cardio:ct-nct04221490- Content hash
01e65720c44cfc50c9dc5add1a8243dc2ea42caac85b84565aa3319df77e0b7a